Efftec International Inc. Announces Acquisition of Teligent Care, Inc.

World News: . []

Nev., Dec. 06, 2018 (GLOBE NEWSWIRE) -- -Efftec International, Inc. (OTC Pink: EFFI) (“Efftec” or the “Company”) is pleased to announce the acquisition of Teligent Care, Inc. (“Teligent”). Teligent has been fully acquired by Efftec, with Efftec remaining as the surviving entity.  Pursuant to the terms of this transaction, shareholders of Teligent have been issued seven million restricted shares of Efftec. 

The Company intends to change its name to “Teligent Care, Inc.” as well as seek a new ticker symbol to better reflect its new business model and enterprise.  In accordance with the terms of the acquisition agreement, Teligent’s CEO, Mr. Paul Cristiano, has joined Efftec as a member of its Board of Directors alongside Efftec’s current CEO, Bruce Collett.

Shareholders and interested parties are invited to visit for information on the Company and its subsidiaries.  The website will be updated regularly to inform our shareholders of all business developments, including acquisitions, mergers and partnerships.

“After an exhaustive search of potential acquisitions, we are incredibly excited to have closed this transaction. We believe that the acquisition of Teligent will greatly enhance Efftec’s shareholder value.  Furthermore, the company has the potential to become a leading competitor in the field of specialized telemedicine.”  Bruce Collett, CEO of Efftec International, commented.  Bruce continued that “In the coming weeks, we will have a chance to more fully elaborate the details of Teligent’s management, business model, accomplishments thus far and plans for the future.”

Paul Cristiano responded: “We thank Efftec’s shareholders and its Board for their vote of confidence and for supporting our vision.  Our goal is to become the preeminent provider of specialized telemedicine services and advanced technologies in the healthcare field. As mentioned by Bruce, I look forward to the opportunity to more fully introduce ourselves and our company to the investing public.” 

Teligent Care is a healthcare company designed to acquire and manage organizations and oversee strategic partners that work interdependently with its fully-owned subsidiary Telecare Partners Group (TPG).  TPG serves the skilled nursing facility sector with specialized and fully-customized telemedicine programs that contain costs, improve productivity, and enhance the quality of medical encounters.  Companies under the Teligent Care brand apply advanced telemedicine technology to deliver on-demand remote medical diagnosis to patients when an on-site doctor is not readily available and critical care is needed.  The company is based in Avon, Connecticut where it serves clients on a national basis.  

Efftec International, Inc (EFFI: OTC) is a diversified holding company whose strategic plan is to acquire interests in young businesses, and provide financing, advice and guidance to assist them in realizing their potential.  It continues to identify and evaluate potential acquisitions that its management believes will create shareholder value and a return on investment. Additional information is available in its filings on otcmarkets.com.  For additional information please email .

Press Releases may include forward-looking statements. In particular, the words “believe,” “may,” “could,” “should,” “expect,” “anticipate,” “estimate,” “project," "propose," "plan," "intend," and similar conditional words and expressions are intended to identify forward-looking statements. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the company. Accordingly, you should not place undue reliance on these forward-looking statements. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The company takes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the company.

Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Efftec International, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Efftec International, Inc. is unable to give any assurance that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company’s ability identify a suitable business model for the corporation.

Contact for information about the company,
Bruce Collett, CEO Efftec International, Inc.
investor@teligentcare.com, or 959-456-0300.

More news and information about Efftec International, Inc.

Published By:

Globe Newswire: 15:15 GMT Thursday 6th December 2018

Published: .

Search for other references to "efftec" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us